What's in ImmunityBio, Inc.'s pipeline?

ImmunityBio, Inc. has 15 drugs in our index: 2 marketed, 0 filed, 2 in Phase 3, 8 in Phase 2, 3 in Phase 1.

Which companies overlap with ImmunityBio, Inc.'s portfolio?

Top competitors by shared drug class: Allife Medical Science and Technology Co., Ltd., Celgene, Kite, A Gilead Company, National Cancer Institute (NCI).

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/immunitybio-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

ImmunityBio, Inc. — Portfolio Competitive Intelligence Brief

ImmunityBio, Inc. pipeline: 2 marketed, 0 filed, 2 Phase 3, 8 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 2 Phase 3 8 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Lovaza	Lovaza	marketed			Other
Anktiva	Anktiva	marketed			Other
NAI + Nivolumab + Ipilimumab	NAI + Nivolumab + Ipilimumab	phase 3	Checkpoint inhibitor combination with NK cell activator	PD-1, CTLA-4, and NK cell activation pathways	Oncology
NAI + Pembrolizumab	NAI + Pembrolizumab	phase 3	STING agonist + PD-1 inhibitor combination	cGAS-STING pathway + PD-1	Oncology

Therapeutic area mix

Oncology · 6
Other · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allife Medical Science and Technology Co., Ltd. · 1 shared drug class
Celgene · 1 shared drug class
Kite, A Gilead Company · 1 shared drug class
National Cancer Institute (NCI) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for ImmunityBio, Inc.:

Cite this brief

Drug Landscape (2026). ImmunityBio, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/immunitybio-inc. Accessed 2026-05-14.